Aurinia Pharmaceuticals Says No Unexpected Safety Signals, Adverse Events Were Observed; Voclosporin Was Generally Well-tolerated; Voclosporin Treated Groups Showed Statistically Significant Improvement Over Control Group In Speed, Rates Of Complete, Part